Myeloid-Derived Suppressor Cells and Cancer
Produktnummer:
18575ccff4b6e640d3ba5ab28b06bad397
Autor: | Breckpot, Karine Escors, David Kochan, Grazyna Talmadge, James E. Van Ginderachter, Jo A. |
---|---|
Themengebiete: | Ex vivo MDSC Differentiation Human and Mouse MDSCs Murine MDSC Differentiation Myeloid-Derived Suppressor Cells (MDSCs) STAT3 Pathway Therapeutic Targeting |
Veröffentlichungsdatum: | 23.03.2016 |
EAN: | 9783319268194 |
Sprache: | Englisch |
Seitenzahl: | 102 |
Produktart: | Kartoniert / Broschiert |
Verlag: | Springer International Publishing |
Produktinformationen "Myeloid-Derived Suppressor Cells and Cancer"
The book starts with an introduction to and history of myeloid-derived suppressor cells (MDSCs), followed by a description of their differentiation, their role in the tumour microenvironment and their therapeutic targeting. It closes with an outlook on future developments. In cancer patients, myelopoiesis is perturbed and instead of generating immunogenic myeloid cells (such as dendritic cells, inflammatory macrophages and granulocytes), there is an increase in highly immature MDSCs. These cells are distributed systemically, resulting in general immunosuppression. They also infiltrate tumours, promoting their progression and metastasis by inhibiting the natural anti-tumour immune response. As these cells also interact with classical anti-neoplastic treatments, they have become major therapeutic targets in the pharmaceutical industry and in oncology research.

Sie möchten lieber vor Ort einkaufen?
Sie haben Fragen zu diesem oder anderen Produkten oder möchten einfach gerne analog im Laden stöbern? Wir sind gerne für Sie da und beraten Sie auch telefonisch.
Juristische Fachbuchhandlung
Georg Blendl
Parcellistraße 5 (Maxburg)
8033 München
Montag - Freitag: 8:15 -18 Uhr
Samstags geschlossen